speb/financial-data huggingface dataset:
ZBIO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2000000.00
ZBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -198000.00
ZBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 78000.00
ZBIO income_statement (annual, 2022-12-31) — Research And Development: 61689000.00
ZBIO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 1000000.00
ZBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: -193279000.00
ZBIO income_statement (annual, 2022-12-31) — Salaries And Wages: 7489000.00
ZBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 13510000.00
ZBIO balance_sheet (annual, 2022-12-31) — Share Issued: 39792381.00
ZBIO income_statement (annual, 2022-12-31) — Special Income Charges: -1000000.00
ZBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 737000.00
ZBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: -192286000.00
ZBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -192286000.00
ZBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ZBIO income_statement (annual, 2022-12-31) — Tax Provision: 0.00
ZBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Assets: 74579000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: -192286000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Debt: 1527000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -192286000.00
ZBIO income_statement (annual, 2022-12-31) — Total Expenses: 75199000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 266865000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6135000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 240898000.00
ZBIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -76199000.00
ZBIO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
ZBIO income_statement (annual, 2022-12-31) — Total Unusual Items: -44144000.00
ZBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -44144000.00
ZBIO balance_sheet (annual, 2022-12-31) — Working Capital: 42477000.00
ZBIO income_statement (annual, 2023-12-31) — +Operating Expense: 77147000.00
ZBIO income_statement (annual, 2023-12-31) — +Total Revenue: 6891798.76
ZBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 5396000.00
ZBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4645000.00
ZBIO cash_flow (annual, 2023-12-31) — Amortization Of Securities: 0.00
ZBIO income_statement (annual, 2023-12-31) — Basic Average Shares: 17415875.00
ZBIO income_statement (annual, 2023-12-31) — Basic EPS: -2.13
ZBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 67295000.00
ZBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -17000.00
ZBIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 813000.00
ZBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
ZBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 56857000.00
ZBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 56857000.00
ZBIO balance_sheet (annual, 2023-12-31) — Cash Financial: 56857000.00
ZBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 20116000.00
ZBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -17000.00
ZBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -30529000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Account Payable: -418000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -3558000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -714000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Payable: -418000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3976000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -3349000.00
ZBIO cash_flow (annual, 2023-12-31) — Change In Working Capital: -8039000.00
ZBIO cash_flow (annual, 2023-12-31) — Changes In Cash: -10430000.00
ZBIO balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
ZBIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: -225721000.00
ZBIO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
ZBIO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 11883000.00
ZBIO balance_sheet (annual, 2023-12-31) — Current Assets: 59804000.00
ZBIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 556000.00
ZBIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 556000.00
ZBIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 23258000.00
ZBIO cash_flow (annual, 2023-12-31) — Depreciation: 113000.00
ZBIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 113000.00
ZBIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 113000.00
ZBIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 17415875.00
ZBIO income_statement (annual, 2023-12-31) — Diluted EPS: -2.13
ZBIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -37124000.00
ZBIO income_statement (annual, 2023-12-31) — EBIT: -27147000.00
ZBIO income_statement (annual, 2023-12-31) — EBITDA: -27034000.00
ZBIO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 78000.00
ZBIO cash_flow (annual, 2023-12-31) — End Cash Position: 56943000.00
ZBIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 20116000.00
ZBIO cash_flow (annual, 2023-12-31) — Free Cash Flow: -30546000.00
ZBIO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -300000.00
ZBIO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 37000.00
ZBIO income_statement (annual, 2023-12-31) — General And Administrative Expense: 17114000.00
ZBIO balance_sheet (annual, 2023-12-31) — Gross PPE: 1014000.00
ZBIO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 301000.00
ZBIO balance_sheet (annual, 2023-12-31) — Invested Capital: -205421000.00
ZBIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -17000.00
ZBIO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ZBIO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 20000000.00
ZBIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 257000.00
ZBIO balance_sheet (annual, 2023-12-31) — Long Term Debt: 20300000.00
ZBIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 20557000.00
ZBIO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 20000000.00
ZBIO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
ZBIO income_statement (annual, 2023-12-31) — Net Income: -37124000.00
ZBIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -37124000.00
ZBIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -37124000.00
ZBIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -37124000.00
ZBIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -37124000.00
ZBIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -37124000.00
ZBIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -37124000.00
ZBIO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
ZBIO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
ZBIO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 20000000.00
ZBIO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 20000000.00
ZBIO balance_sheet (annual, 2023-12-31) — Net PPE: 1014000.00
ZBIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -17000.00
ZBIO cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
ZBIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -225721000.00
ZBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 1388000.00
ZBIO balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 5788000.00
ZBIO income_statement (annual, 2023-12-31) — Normalized EBITDA: -16734000.00
ZBIO income_statement (annual, 2023-12-31) — Normalized Income: -28987000.00
ZBIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -30529000.00
ZBIO income_statement (annual, 2023-12-31) — Operating Income: -27147000.00
ZBIO income_statement (annual, 2023-12-31) — Operating Revenue: 6891798.76
ZBIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 39792381.00
ZBIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 2947000.00
ZBIO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 37000.00
ZBIO income_statement (annual, 2023-12-31) — Other Gand A: 7255000.00
ZBIO income_statement (annual, 2023-12-31) — Other Income Expense: -9676000.00
ZBIO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 11026000.00
ZBIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 186000.00
ZBIO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 624000.00
ZBIO balance_sheet (annual, 2023-12-31) — Other Properties: 1014000.00
ZBIO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
ZBIO income_statement (annual, 2023-12-31) — Other Special Charges: 10000000.00
ZBIO balance_sheet (annual, 2023-12-31) — Payables: 5697000.00
ZBIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 17580000.00
ZBIO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5122000.00
ZBIO balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 250086000.00
ZBIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
ZBIO cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
ZBIO income_statement (annual, 2023-12-31) — Pretax Income: -36823000.00
ZBIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 116000.00
ZBIO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
ZBIO cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
ZBIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -17000.00
ZBIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 113000.00
ZBIO income_statement (annual, 2023-12-31) — Research And Development: 60033000.00
ZBIO balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
ZBIO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 10000000.00
ZBIO balance_sheet (annual, 2023-12-31) — Retained Earnings: -230403000.00
ZBIO income_statement (annual, 2023-12-31) — Salaries And Wages: 9859000.00
ZBIO cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
ZBIO income_statement (annual, 2023-12-31) — Selling General And Administration: 17114000.00
ZBIO balance_sheet (annual, 2023-12-31) — Share Issued: 39792381.00
ZBIO income_statement (annual, 2023-12-31) — Special Income Charges: -10000000.00
ZBIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3495000.00
ZBIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: -225721000.00
ZBIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -225721000.00
ZBIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2163000.00
ZBIO income_statement (annual, 2023-12-31) — Tax Provision: 301000.00
ZBIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
ZBIO balance_sheet (annual, 2023-12-31) — Total Assets: 68180000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Capitalization: -205421000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Debt: 21113000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -225721000.00
ZBIO income_statement (annual, 2023-12-31) — Total Expenses: 77147000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 293901000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 8376000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 270643000.00
ZBIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -37147000.00
ZBIO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 301000.00
ZBIO income_statement (annual, 2023-12-31) — Total Unusual Items: -10300000.00
ZBIO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -10300000.00
ZBIO balance_sheet (annual, 2023-12-31) — Working Capital: 36546000.00
ZBIO cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -439000.00
ZBIO cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
ZBIO balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 0.00
ZBIO income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
ZBIO balance_sheet (quarterly, 2024-09-30) — Preferred Securities Outside Stock Equity: 0.00
ZBIO cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
ZBIO income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
ZBIO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
ZBIO income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
ZBIO income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
ZBIO income_statement (annual, 2024-12-31) — +Operating Expense: 168888000.00
ZBIO income_statement (annual, 2024-12-31) — +Total Revenue: 5000000.00
ZBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 17136000.00
ZBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 699651000.00
ZBIO cash_flow (annual, 2024-12-31) — Amortization Of Securities: -602000.00
ZBIO income_statement (annual, 2024-12-31) — Basic Average Shares: 13198960.00
ZBIO income_statement (annual, 2024-12-31) — Basic EPS: -11.89
ZBIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 56943000.00
ZBIO cash_flow (annual, 2024-12-31) — Capital Expenditure: -131000.00
ZBIO cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -74000.00
ZBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1003000.00
ZBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 4000.00
ZBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 319742000.00
ZBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 350766000.00
ZBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 412958000.00
ZBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -30552000.00
ZBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -119674000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Account Payable: 11740000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 22065000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -673000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Payable: 11740000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 33805000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -7701000.00
ZBIO cash_flow (annual, 2024-12-31) — Change In Working Capital: 25431000.00
ZBIO cash_flow (annual, 2024-12-31) — Changes In Cash: 262732000.00
ZBIO balance_sheet (annual, 2024-12-31) — Common Stock: 4000.00
ZBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 312458000.00
ZBIO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 240636000.00
ZBIO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 6249000.00
ZBIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 30852000.00
ZBIO balance_sheet (annual, 2024-12-31) — Current Assets: 355923000.00
ZBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 785000.00
ZBIO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 785000.00
ZBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 57292000.00
ZBIO cash_flow (annual, 2024-12-31) — Depreciation: 137000.00
ZBIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 137000.00
ZBIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 137000.00
ZBIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 13198960.00
ZBIO income_statement (annual, 2024-12-31) — Diluted EPS: -11.89
ZBIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -156988000.00
ZBIO income_statement (annual, 2024-12-31) — EBIT: -156559000.00
ZBIO income_statement (annual, 2024-12-31) — EBITDA: -156422000.00
ZBIO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 157000.00
ZBIO cash_flow (annual, 2024-12-31) — End Cash Position: 319832000.00
ZBIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 412958000.00
ZBIO cash_flow (annual, 2024-12-31) — Free Cash Flow: -119805000.00
ZBIO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ZBIO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -846000.00
ZBIO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 194000.00
ZBIO income_statement (annual, 2024-12-31) — General And Administrative Expense: 29749000.00
ZBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 1189000.00
ZBIO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 211000.00
ZBIO income_statement (annual, 2024-12-31) — Interest Expense: 0.00
ZBIO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
ZBIO income_statement (annual, 2024-12-31) — Interest Income: 7973000.00
ZBIO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 7973000.00
ZBIO balance_sheet (annual, 2024-12-31) — Invested Capital: 312458000.00
ZBIO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -30552000.00
ZBIO balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
ZBIO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 419017000.00
ZBIO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
ZBIO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 218000.00
ZBIO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 218000.00
ZBIO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
ZBIO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
ZBIO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 240636000.00
ZBIO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 6249000.00
ZBIO income_statement (annual, 2024-12-31) — Net Income: -156988000.00
ZBIO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -156988000.00
ZBIO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -156988000.00
ZBIO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -156988000.00
ZBIO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -156988000.00
ZBIO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -156988000.00
ZBIO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -156988000.00
ZBIO cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
ZBIO income_statement (annual, 2024-12-31) — Net Interest Income: 7973000.00
ZBIO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -30421000.00
ZBIO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ZBIO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ZBIO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ZBIO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ZBIO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 7973000.00
ZBIO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -6334000.00
ZBIO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -4473000.00
ZBIO balance_sheet (annual, 2024-12-31) — Net PPE: 1189000.00
ZBIO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -131000.00
ZBIO cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 178381000.00
ZBIO cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 312458000.00
ZBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 0.00
ZBIO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 12639000.00
ZBIO income_statement (annual, 2024-12-31) — Normalized EBITDA: -155576000.00
ZBIO income_statement (annual, 2024-12-31) — Normalized Income: -156319660.00
ZBIO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -119674000.00
ZBIO income_statement (annual, 2024-12-31) — Operating Income: -163888000.00
ZBIO income_statement (annual, 2024-12-31) — Operating Revenue: 5000000.00
ZBIO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 41793412.00
ZBIO balance_sheet (annual, 2024-12-31) — Other Current Assets: 5067000.00
ZBIO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 194000.00
ZBIO income_statement (annual, 2024-12-31) — Other Gand A: 10328000.00
ZBIO income_statement (annual, 2024-12-31) — Other Income Expense: -644000.00
ZBIO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1527000.00
ZBIO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 217000.00
ZBIO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 202000.00
ZBIO balance_sheet (annual, 2024-12-31) — Other Properties: 1189000.00
ZBIO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 31024000.00
ZBIO balance_sheet (annual, 2024-12-31) — Payables: 17347000.00
ZBIO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 48199000.00
ZBIO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8308000.00
ZBIO balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
ZBIO balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
ZBIO cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 178381000.00
ZBIO cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
ZBIO income_statement (annual, 2024-12-31) — Pretax Income: -156559000.00
ZBIO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 275000.00
ZBIO cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
ZBIO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -36421000.00
ZBIO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -131000.00
ZBIO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 137000.00
ZBIO income_statement (annual, 2024-12-31) — Research And Development: 139139000.00
ZBIO balance_sheet (annual, 2024-12-31) — Restricted Cash: 90000.00
ZBIO balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 90000.00
ZBIO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
ZBIO income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Retained Earnings: -387391000.00
ZBIO income_statement (annual, 2024-12-31) — Salaries And Wages: 19421000.00
ZBIO cash_flow (annual, 2024-12-31) — Sale Of Investment: 6000000.00
ZBIO income_statement (annual, 2024-12-31) — Selling General And Administration: 29749000.00
ZBIO balance_sheet (annual, 2024-12-31) — Share Issued: 41793412.00
ZBIO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
ZBIO income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
ZBIO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10821000.00
ZBIO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 312458000.00
ZBIO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 312458000.00
ZBIO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -177660.00
ZBIO income_statement (annual, 2024-12-31) — Tax Provision: 429000.00
ZBIO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ZBIO balance_sheet (annual, 2024-12-31) — Total Assets: 369968000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Capitalization: 312458000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Debt: 1003000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 312458000.00
ZBIO income_statement (annual, 2024-12-31) — Total Expenses: 168888000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 57510000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 14045000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 218000.00
ZBIO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -163888000.00
ZBIO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 211000.00
ZBIO income_statement (annual, 2024-12-31) — Total Unusual Items: -846000.00
ZBIO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
ZBIO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -846000.00
ZBIO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ZBIO balance_sheet (annual, 2024-12-31) — Working Capital: 298631000.00
ZBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 47330000.00
ZBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 10000000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 20018000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 705136000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -382000.00
ZBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 41800802.00
ZBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.80
ZBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 319832000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -18000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1225000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 196554000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 312379000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 99000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -86274000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -37051000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2882000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -11165000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -222000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Payable: 2882000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -8283000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -353000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -8858000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -123226000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Common Stock: 4000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 284317000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 24818000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Current Assets: 317807000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 908000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 908000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 49132000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Depreciation: 23000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 23000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 23000.00
ZBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 41800802.00
ZBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.80
ZBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — EBIT: -33778000.00
ZBIO income_statement (quarterly, 2025-03-31) — EBITDA: -33755000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -52000.00
ZBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 196554000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 99000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -37069000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 107000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 141000.00
ZBIO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12415000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1276000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 5000.00
ZBIO income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
ZBIO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
ZBIO income_statement (quarterly, 2025-03-31) — Interest Income: 3394000.00
ZBIO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3394000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 284317000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -86274000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1835000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
ZBIO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 317000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 317000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
ZBIO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Income: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -33573000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -33573000.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: 3394000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -86256000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
ZBIO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
ZBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3394000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Net PPE: 1276000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -18000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 284317000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 12639000.00
ZBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -33755000.00
ZBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -33573000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -37051000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 107000.00
ZBIO income_statement (quarterly, 2025-03-31) — Operating Income: -37330000.00
ZBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 10000000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 41821887.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5428000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 141000.00
ZBIO income_statement (quarterly, 2025-03-31) — Other Gand A: 3707000.00
ZBIO income_statement (quarterly, 2025-03-31) — Other Income Expense: 158000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 246000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 209000.00
ZBIO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 158000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Other Properties: 1276000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 115825000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Payables: 20023000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 44841000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3383000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
ZBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -33778000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 99000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -99114000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -18000.00
ZBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 23000.00
ZBIO income_statement (quarterly, 2025-03-31) — Research And Development: 34915000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 0.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -420964000.00
ZBIO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 8708000.00
ZBIO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 12858000.00
ZBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12415000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Share Issued: 41821887.00
ZBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 5386000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 284317000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 284317000.00
ZBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ZBIO income_statement (quarterly, 2025-03-31) — Tax Provision: -205000.00
ZBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.01
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Assets: 333766000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 284317000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Debt: 1225000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 284317000.00
ZBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 47330000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 49449000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15959000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 317000.00
ZBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -37330000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 5000.00
ZBIO balance_sheet (quarterly, 2025-03-31) — Working Capital: 268675000.00
ZBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 55163000.00
ZBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 7931000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 712903000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -935000.00
ZBIO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 41865400.00
ZBIO income_statement (quarterly, 2025-06-30) — Basic EPS: -1.25
ZBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 196554000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1008000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 44006000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 273279000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1722000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -112291000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -41743000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -12087000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 16314000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -224000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Payable: -12087000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 4227000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1155000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 5158000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -152312000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 4000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 239626000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 38472000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 278603000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 793000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 793000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 53244000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Depreciation: 12000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 12000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 12000.00
ZBIO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 41865400.00
ZBIO income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.25
ZBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -52223000.00
ZBIO income_statement (quarterly, 2025-06-30) — EBIT: -55163000.00
ZBIO income_statement (quarterly, 2025-06-30) — EBITDA: -55151000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -236000.00
ZBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 44006000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1722000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -41743000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -94000.00
ZBIO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12136000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1071000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 239626000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -112291000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1614000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 215000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 215000.00
ZBIO income_statement (quarterly, 2025-06-30) — Net Income: -52223000.00
ZBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -52223000.00
ZBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -52223000.00
ZBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -52223000.00
ZBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -52223000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -52223000.00
ZBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -52223000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -112291000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 1071000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 239626000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 11707000.00
ZBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -55151000.00
ZBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -52223000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -41743000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
ZBIO income_statement (quarterly, 2025-06-30) — Operating Income: -55163000.00
ZBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 42088697.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 5324000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -94000.00
ZBIO income_statement (quarterly, 2025-06-30) — Other Gand A: 4029000.00
ZBIO income_statement (quarterly, 2025-06-30) — Other Income Expense: 2960000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 200000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 90000.00
ZBIO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2960000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Other Properties: 1071000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 229273000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Payables: 7931000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 46403000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6048000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
ZBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -52203000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1722000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -126553000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
ZBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 12000.00
ZBIO income_statement (quarterly, 2025-06-30) — Research And Development: 43027000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -473187000.00
ZBIO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 8107000.00
ZBIO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 14262000.00
ZBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 12136000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 42088697.00
ZBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6045000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 239626000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 239626000.00
ZBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ZBIO income_statement (quarterly, 2025-06-30) — Tax Provision: 20000.00
ZBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 293085000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 239626000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Debt: 1008000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 239626000.00
ZBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 55163000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 53459000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 14482000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 215000.00
ZBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -55163000.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
ZBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: 225359000.00
ZBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 47580000.00
ZBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6444000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 721179000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -193000.00
ZBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 42159340.00
ZBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -1.22
ZBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 44006000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5000000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 798000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 115565000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 290884000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 72616000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 40043000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -41125000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1954000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 102000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -211000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Payable: -1954000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1852000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1601000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -3664000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 71534000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 4000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 196428000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 36602000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 296642000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 618000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 618000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 52421000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Depreciation: 11000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 11000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 11000.00
ZBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 42159340.00
ZBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.22
ZBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -51499000.00
ZBIO income_statement (quarterly, 2025-09-30) — EBIT: -47580000.00
ZBIO income_statement (quarterly, 2025-09-30) — EBITDA: -47569000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 25000.00
ZBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 115565000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 72616000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -46125000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00